by Vandana Singh | Apr 28, 2026 | General
The U.S. Food and Drug Administration (FDA) on Tuesday cleared PRF Technologies Ltd.’s (NASDAQ:PRFX) Investigational New Drug application for OcuRing-K, enabling the company to move into a Phase 2 trial targeting pain and inflammation following cataract surgery....
by Avi Kapoor | Apr 28, 2026 | General
On CNBC’s “Mad Money Lightning Round,” Jim Cramer said Joby Aviation (NASDAQ:JOBY) is “way too risky.” “If you’re just starting out, I want you to be in something that could actually go up over time, and you don’t feel like you get disgusted if it...
by Avi Kapoor | Apr 28, 2026 | General
On CNBC’s “Halftime Report Final Trades,” Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, said The Goldman Sachs Group, Inc. (NYSE:GS) is holding on well following a sell-off after earnings results and has bounced...
by Rishabh Mishra | Apr 28, 2026 | General
U.S. Senator Elizabeth Warren (D-Mass.) is sounding the alarm on the soaring artificial intelligence (AI) market, likening Big Tech’s AI expansion to the 2008 financial crisis. This political scrutiny arrives just as “The Big Short” investor Michael Burry places...
by Kaustubh Bagalkote | Apr 28, 2026 | General
ArcBest Corporation (NASDAQ:ARCB) cleared Wall Street’s bar on earnings and revenue Tuesday, but tighter margins in its core trucking segment tell a more cautious story. ArcBest reported non-GAAP net income of $7.2 million for the first quarter of 2026, or 32 cents...
Recent Comments